Three monthly doses of palivizumab are not adequate for 5-month protection: A population pharmacokinetic analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Three monthly doses of palivizumab are not adequate for 5-month protection: A population pharmacokinetic analysis

Published:2013-12 Issue:6 Volume:26 Page:666-671
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

La Via William V.,Notario Gerard F.,Yu Xiang-Qing,Sharma Shringi,Noertersheuser Peter A.,Robbie Gabriel J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference34 articles.

1. Nosocomial respiratory syncytial virus infections: the “Cold War” has not ended;Hall;Clin Infect Dis,2000

2. Respiratory syncytial virus infection;Simoes;Lancet,1999

3. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response;Zhang;J Virol,2008

4. Respiratory syncytial virus. Textbook of pediatric infectious diseases;Hall,2009

5. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006;Stockman;Pediatr Infect Dis J,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of respiratory syncytial virus in hospitalized children over a 9-year period and preventive strategy impact;Frontiers in Pharmacology;2024-05-22

2. Exploring the adoption of less restricted criteria for respiratory syncytial virus prophylaxis in late preterm infants: insights from a retrospective analysis;Frontiers in Pediatrics;2023-06-08

3. Impact of immunoprophylaxis with palivizumab on respiratory syncytial virus infection in preterm infants less than 35 weeks in Colombian hospitals;Pediatric Pulmonology;2022-07-15

4. Effect of delayed palivizumab administration on respiratory syncytial virus infection-related hospitalisation;Medicine;2021-11-24

5. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children;Cochrane Database of Systematic Reviews;2021-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3